C4 Therapeutics
CCCC
#8679
Rank
A$0.25 B
Marketcap
A$2.63
Share price
-8.23%
Change (1 day)
-51.31%
Change (1 year)

Earnings for C4 Therapeutics (CCCC)

Earnings in 2025 (TTM): -A$0.19 Billion

According to C4 Therapeutics's latest financial reports the company's current earnings are A$30.1 Million. In 2024 the company made an earning of -A$0.17 Billion, an increase over its 2023 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for C4 Therapeutics from 2020 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.19 Billion11.56%
2024 -A$0.17 Billion-12.27%
2023 -A$0.19 Billion3.08%
2022 -A$0.18 Billion54.08%
2021 -A$0.12 Billion25.35%
2020 -A$93.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.22 Billion 27.84%๐Ÿ‡บ๐Ÿ‡ธ USA